Pages that link to "Q39001985"
Jump to navigation
Jump to search
The following pages link to Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes (Q39001985):
Displaying 50 items.
- Research into cancer metabolomics: Towards a clinical metamorphosis (Q26781245) (← links)
- Metabolic pathways promoting cancer cell survival and growth (Q28086940) (← links)
- dATF4 regulation of mitochondrial folate-mediated one-carbon metabolism is neuroprotective (Q30844494) (← links)
- A New Approach for Identification of Cancer-related Pathways using Protein Networks and Genomic Data. (Q31093592) (← links)
- One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy (Q33618935) (← links)
- Autism and Intellectual Disability-Associated KIRREL3 Interacts with Neuronal Proteins MAP1B and MYO16 with Potential Roles in Neurodevelopment (Q35527346) (← links)
- Positive correlation between expression level of mitochondrial serine hydroxymethyltransferase and breast cancer grade (Q35624231) (← links)
- Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway (Q36025884) (← links)
- Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancer (Q36201682) (← links)
- Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker (Q37321209) (← links)
- NF-Y activates genes of metabolic pathways altered in cancer cells (Q38294889) (← links)
- Identification of TWIST-interacting genes in prostate cancer. (Q38719560) (← links)
- miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma (Q38812064) (← links)
- Serine and one-carbon metabolism in cancer (Q38955873) (← links)
- One-Carbon Metabolism in Health and Disease (Q38957946) (← links)
- Upregulation of PSMB4 is Associated with the Necroptosis after Spinal Cord Injury (Q39499057) (← links)
- Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility Loci (Q39597050) (← links)
- PSMB4 expression associates with epithelial ovarian cancer growth and poor prognosis. (Q40462951) (← links)
- Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma (Q40982895) (← links)
- Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transition (Q40996336) (← links)
- Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas (Q41200567) (← links)
- Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. (Q41868960) (← links)
- Discovery of Tamoxifen and N-Desmethyl Tamoxifen Protein Targets in MCF-7 Cells Using Large-Scale Protein Folding and Stability Measurements. (Q47777575) (← links)
- The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer (Q50062142) (← links)
- Proteasome dysregulation in human cancer: implications for clinical therapies (Q50077966) (← links)
- Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma (Q50089755) (← links)
- Proteasome beta-4 subunit contributes to the development of melanoma and is regulated by miR-148b (Q50557428) (← links)
- Long-lived rodents reveal signatures of positive selection in genes associated with lifespan (Q51760196) (← links)
- Up-regulation of PSMB4 is associated with neuronal apoptosis after neuroinflammation induced by lipopolysaccharide. (Q53576549) (← links)
- Inhibiting Glycine Decarboxylase Suppresses Pyruvate-to-Lactate Metabolism in Lung Cancer Cells. (Q55252236) (← links)
- SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma (Q57110767) (← links)
- Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact (Q57272563) (← links)
- Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis (Q58115601) (← links)
- An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer (Q58790272) (← links)
- Long noncoding RNA LINC01234 promotes serine hydroxymethyltransferase 2 expression and proliferation by competitively binding miR-642a-5p in colon cancer (Q61796562) (← links)
- Glycine decarboxylase induces autophagy and is downregulated by miRNA-30d-5p in hepatocellular carcinoma (Q64104124) (← links)
- Curcumin and its Potential for Systemic Targeting of Inflamm-Aging and Metabolic Reprogramming in Cancer (Q64115556) (← links)
- Circumventing senescence is associated with stem cell properties and metformin sensitivity (Q64261530) (← links)
- NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview (Q89944614) (← links)
- High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients (Q90457890) (← links)
- Novel Pyrrolo[3,2-d]pyrimidine Compounds Target Mitochondrial and Cytosolic One-carbon Metabolism with Broad-spectrum Antitumor Efficacy (Q91753121) (← links)
- Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression (Q91833664) (← links)
- Downregulating Serine Hydroxymethyltransferase 2 Deteriorates Hepatic Ischemia-Reperfusion Injury through ROS/JNK/P53 Signaling in Mice (Q91900107) (← links)
- Joint Transcriptomic Analysis of Lung Cancer and Other Lung Diseases (Q92189114) (← links)
- ERRα activates SHMT2 transcription to enhance the resistance of breast cancer to lapatinib via modulating the mitochondrial metabolic adaption (Q92370310) (← links)
- Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells (Q92401682) (← links)
- Architecture of The Human Ape1 Interactome Defines Novel Cancers Signatures (Q92491647) (← links)
- Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer (Q92744205) (← links)
- Structural Basis of BRCC36 Function in DNA Repair and Immune Regulation (Q93114616) (← links)
- SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia (Q94550700) (← links)